tirzepatide shortage update Do you have questions about now that the FDA removed it from the list? Join our office hours session to discuss this news as well as how to remain compliant What are the changes to

The presence of a high number of light-responsive elements also indicates that light plays an important role in the regulation of GST activity and gene expression

"Emerging Pharmacotherapies for Obesity: A Systematic Review"

Didn't think it was going to work

Key Takeaways Tirzepatide vs semaglutide comes down to dual agonist vs single agonist: tirzepatide targets both GLP-1 and GIP receptors, while semaglutide targets GLP-1 alone The only head-to-head trial (SURPASS-2) found tirzepatide superior to semaglutide for both blood sugar control and weight loss In separate obesity trials, tirzepatide 15mg achieved 20.9% weight loss at 72 weeks vs semaglutide 2.4mg's 14.9% at 68 weeks Semaglutide has proven cardiovascular benefit (SELECT trial: 20% MACE reduction)